SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-22-001032
Filing Date
2022-08-04
Accepted
2022-08-04 08:00:36
Documents
13
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EDGEWISE THERAPEUTICS, INC. 8-K a52801668.htm   iXBRL 8-K 29329
2 EXHIBIT 99.1 a52801668ex99_1.htm EX-99.1 54964
  Complete submission text file 0001157523-22-001032.txt   232909

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20220804.xsd EX-101.SCH 3929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20220804_lab.xml EX-101.LAB 23288
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20220804_pre.xml EX-101.PRE 16554
7 EXTRACTED XBRL INSTANCE DOCUMENT a52801668_htm.xml XML 4225
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 221134767
SIC: 2834 Pharmaceutical Preparations